These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25669488)

  • 1. Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3-gallate and related polyphenols.
    Glynn SJ; Gaffney KJ; Sainz MA; Louie SG; Petasis NA
    Org Biomol Chem; 2015 Apr; 13(13):3887-99. PubMed ID: 25669488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.
    Golden EB; Lam PY; Kardosh A; Gaffney KJ; Cadenas E; Louie SG; Petasis NA; Chen TC; Schönthal AH
    Blood; 2009 Jun; 113(23):5927-37. PubMed ID: 19190249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism.
    Modernelli A; Naponelli V; Giovanna Troglio M; Bonacini M; Ramazzina I; Bettuzzi S; Rizzi F
    Sci Rep; 2015 Oct; 5():15270. PubMed ID: 26471237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselective synthesis of adamantylalanine and carboranylalanine and their incorporation into the proteasome inhibitor bortezomib.
    de Bruin G; Mock ED; Hoogendoorn S; van den Nieuwendijk AM; Mazurek J; van der Marel GA; Florea BI; Overkleeft HS
    Chem Commun (Camb); 2016 Mar; 52(21):4064-7. PubMed ID: 26894389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells.
    Kuhn D; Lam WH; Kazi A; Daniel KG; Song S; Chow LM; Chan TH; Dou QP
    Front Biosci; 2005 May; 10():1010-23. PubMed ID: 15769601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea.
    Du GJ; Zhang Z; Wen XD; Yu C; Calway T; Yuan CS; Wang CZ
    Nutrients; 2012 Nov; 4(11):1679-91. PubMed ID: 23201840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design.
    Schrader J; Henneberg F; Mata RA; Tittmann K; Schneider TR; Stark H; Bourenkov G; Chari A
    Science; 2016 Aug; 353(6299):594-8. PubMed ID: 27493187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory Effects of (-)-Epigallocatechin-3-gallate on Esophageal Cancer.
    Wang LX; Shi YL; Zhang LJ; Wang KR; Xiang LP; Cai ZY; Lu JL; Ye JH; Liang YR; Zheng XQ
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30857144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea.
    Bannerman B; Xu L; Jones M; Tsu C; Yu J; Hales P; Monbaliu J; Fleming P; Dick L; Manfredi M; Claiborne C; Bolen J; Kupperman E; Berger A
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1145-54. PubMed ID: 21400028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of catechol-Omicron-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG.
    Landis-Piwowar K; Chen D; Chan TH; Dou QP
    Oncol Rep; 2010 Aug; 24(2):563-9. PubMed ID: 20596647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the green tea polyphenols catechin-3-gallate (CG) and epicatechin-3-gallate (ECG) as proteasome inhibitors.
    Wan SB; Chen D; Dou QP; Chan TH
    Bioorg Med Chem; 2004 Jul; 12(13):3521-7. PubMed ID: 15186836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG].
    Lam WH; Kazi A; Kuhn DJ; Chow LM; Chan AS; Dou QP; Chan TH
    Bioorg Med Chem; 2004 Nov; 12(21):5587-93. PubMed ID: 15465336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of green tea polyphenols.
    Dou QP
    Nutr Cancer; 2009; 61(6):827-35. PubMed ID: 20155623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of (-)-epigallocatechin-3-gallate-induced apoptosis by bortezomib in multiple myeloma cells.
    Wang Q; Li J; Gu J; Huang B; Zhao Y; Zheng D; Ding Y; Zeng L
    Acta Biochim Biophys Sin (Shanghai); 2009 Dec; 41(12):1018-26. PubMed ID: 20011976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel aromatic sulfonyl naphthalene-based boronates as 20S proteasome inhibitors.
    Liu H; Wu J; Ge Y; Li A; Li J; Liu Z; Xu Y; Xu Q; Li Y
    Bioorg Med Chem; 2018 Mar; 26(5):1050-1061. PubMed ID: 29426629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin-3-gallate plays an antagonistic role in the antitumor effect of bortezomib in myeloma cells via activating Wnt/β-catenin signaling pathway.
    Qiu X; Wu X; He W
    Adv Clin Exp Med; 2022 Jul; 31(7):789-794. PubMed ID: 35394126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of green tea polyphenols affects their binding to and inhibitory poses of the proteasome beta5 subunit.
    Daniel KG; Landis-Piwowar KR; Chen D; Wan SB; Chan TH; Dou QP
    Int J Mol Med; 2006 Oct; 18(4):625-32. PubMed ID: 16964415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols.
    Landis-Piwowar KR; Wan SB; Wiegand RA; Kuhn DJ; Chan TH; Dou QP
    J Cell Physiol; 2007 Oct; 213(1):252-60. PubMed ID: 17477351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo.
    Nam S; Smith DM; Dou QP
    J Biol Chem; 2001 Apr; 276(16):13322-30. PubMed ID: 11278274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors.
    Kazi A; Wang Z; Kumar N; Falsetti SC; Chan TH; Dou QP
    Anticancer Res; 2004; 24(2B):943-54. PubMed ID: 15161048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.